4.6 Article

Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans

期刊

PLOS ONE
卷 8, 期 12, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0082163

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Ministry of Health, Labour and Welfare of Japan
  3. Japan Science and Technology Agency, PRESTO
  4. Takeda Science Foundation
  5. Ono Medical Research Foundation
  6. Japan Research Foundation for Clinical Pharmacology
  7. Nestle Nutrition Council, Japan
  8. Astellas Foundation for Research on Metabolic Disorders
  9. Uehara Memorial Foundation
  10. Medical Research Institute, Tokyo Medical and Dental University
  11. Grants-in-Aid for Scientific Research [21117007, 25670439, 24790916] Funding Source: KAKEN

向作者/读者索取更多资源

Although macrophages are thought to be crucial for the pathogenesis of chronic inflammatory diseases, how they are involved in disease progression from simple steatosis to non-alcoholic steatohepatitis (NASH) is poorly understood. Here we report the unique histological structure termed hepatic crown-like structures (hCLS) in the mouse model of human NASH; melanocortin-4 receptor deficient mice fed a Western diet. In hCLS, CD11c-positive macrophages aggregate to surround hepatocytes with large lipid droplets, which is similar to those described in obese adipose tissue. Histological analysis revealed that hCLS is closely associated with activated fibroblasts and collagen deposition. When treatment with clodronate liposomes effectively depletes macrophages scattered in the liver, with those in hCLS intact, hepatic expression of inflammatory and fibrogenic genes is unaffected, suggesting that hCLS is an important source of inflammation and fibrosis during the progression of NASH. Notably, the number of hCLS is positively correlated with the extent of liver fibrosis. We also observed increased number of hCLS in the liver of non-alcoholic fatty liver disease/NASH patients. Collectively, our data provide evidence that hCLS is involved in the development of hepatic inflammation and fibrosis, thereby suggesting its pathophysiologic role in disease progression from simple steatosis to NASH.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据